19 May, 2025 Kigali, Rwanda and San Francisco, USA

Bio Usawa is pleased to announce that CEO Menghis Bairu, MD, will be a featured speaker at the upcoming 10th Annual African Diaspora Investment Symposium, to be held 28-30 May, 2025 in Washington, DC.

The focus of his session will be ‘African Diaspora Entrepreneurship and Investment’, a key component of growing meaningful and sustainable change in Africa.

The topic is especially relevant to Bio Usawa’s core Vision and Mission, both of which describe our commitment to delivering affordable and accessible monoclonal antibody-based therapies for cancer, ophthalmic, autoimmune, and infectious diseases in Africa. 

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.